13F Holdings
中文EN

ECIA ENCISION INC

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 930775 · Fiscal year ends 03/31

Financial factors as of 2025-09-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.0%
TTM net income YoY45.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—

Margins

Gross margin52.6%
Operating margin-5.1%
Net margin-6.0%
FCF margin-8.6%
EBITDA margin-3.7%

Returns

ROE-21.4%
ROA-10.1%
ROIC (approx.)-15.5%
Asset turnover1.66x

Leverage & solvency

Liabilities / assets54.0%
Debt / equity0.00x
Current ratio2.28x
Interest coverage-5.69x

Cash quality & payout

Operating cash flow / net income1.29x
Accruals ratio2.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31FY20212021-03-31
Income statement
Revenue$6.56M$6.59M$7.35M$7.67M$7.54M
Cost of revenue$3.04M$3.45M$3.32M$3.88M$3.63M
Gross profit$3.51M$3.14M$4.03M$3.79M$3.91M
R&D expense$593,152$621,894$816,119$918,155$569,542
SG&A expense$1.40M$1.52M$1.49M$1.38M$1.38M
Operating income-$171,980-$640,783-$302,797-$594,934-$61,641
Interest expense$43,723$62,373$19,529$7,224$87,127
Pretax income-$220,198-$691,783-$323,945-$65,594$584,734
Income tax$0$0$0$0$0
Net income-$220,198-$691,783-$323,945-$65,594$584,734
EBITDA-$90,587-$555,565-$215,891-$481,464$27,314
EPS (basic)-0.02-0.06-0.03-0.010.05
EPS (diluted)-0.02-0.06-0.03-0.010.05
Weighted avg. shares (diluted)11.88M11.77M11.76M11.63M11.77M
Balance sheet
Cash & equivalents$257,433$42,509$188,966$949,645$1.47M
Receivables$786,471$891,129$920,721$947,623$1.02M
Inventory$1.48M$1.40M$1.90M$1.58M$1.45M
Current assets$2.61M$2.43M$3.12M$3.60M$4.10M
PP&E, net$244,757$254,004$303,276$189,297$265,717
Intangibles$171,890$164,010$163,133$180,719$213,368
Total assets$3.67M$3.81M$4.13M$4.79M$5.66M
Current liabilities$1.58M$1.07M$1.13M$1.28M$1.18M
Short-term debt——$227,300—$227,300
Total liabilities$2.02M$1.98M$1.64M$2.05M$2.86M
Shareholders' equity$1.65M$1.83M$2.49M$2.75M$2.80M
Shares outstanding11.88M11.86M11.77M11.72M11.58M
Cash flow statement
Operating cash flow-$54,948$144,389-$861,485-$444,432$219,946
Capital expenditure$54,415$12,050$173,269$17,550$30,020
Free cash flow-$109,363$132,339-$1.03M-$461,982$189,926
Investing cash flow-$80,025-$36,823-$183,299-$35,401-$45,186
Financing cash flow$349,897-$254,023$284,105-$44,861$914,447
Depreciation & amortization$81,393$85,218$86,906$113,470$88,955
Stock-based compensation$46,001$53,552$51,892$40,853$33,354

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.